PATENT CLAIM ANALYSIS

Application Number: 16343271
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["546", "153000"]

Abstract:
The present application provides a quinolyl-substituted carboxylic acid compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, as well as a method for preparing the compound, a use of the compound, and a formulation containing the quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof. This type of compounds are inhibitors for AXL and/or VEGFR2 protein kinase, and can be used to treat diseases caused by abnormality of the two protein kinases, such as, tumor, etc.;

Claim (Index 4):
The quinolyl-substituted carboxylic acid compound or the pharmaceutically acceptable salt thereof according to  claim 1 , wherein V 1  and V 2  are each independently selected from hydrogen, deuterium, and halogen, R is C 1-12  alkoxy, and L is C 1-12  alkylene.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 100.0
- Lexical Diversity: 1.58621
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14345922', '13819560', '13308287', '10420466', '12228421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8048712407670007
- 35 USC 102 Novelty (BERT): 0.5163087295813981
- Combined Prediction Score: 0.7760149896484405
- Mean Citation Score: 286.6710240000001
- Max Citation Score: 328.88113
- Similarity Product: 275.43840900209307

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test